Utibron Neohaler Side Effects
Generic name: glycopyrrolate / indacaterol
Medically reviewed by Drugs.com. Last updated on Sep 16, 2022.
Note: This document contains side effect information about glycopyrrolate / indacaterol. Some dosage forms listed on this page may not apply to the brand name Utibron Neohaler.
Applies to glycopyrrolate/indacaterol: inhalation capsule.
Serious side effects of Utibron Neohaler
Along with its needed effects, glycopyrrolate / indacaterol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking glycopyrrolate / indacaterol:
- Blurred vision
- body aches or pain
- chest pain
- difficulty in breathing
- dry mouth
- ear congestion
- flushed, dry skin
- fruit-like breath odor
- increased hunger
- increased thirst
- increased urination
- loss of voice
- pounding in the ears
- runny or stuffy nose
- slow or fast heartbeat
- sore throat
- stomach pain
- tightness in the chest
- unexplained weight loss
- unusual tiredness or weakness
- Bloating or swelling of the face, arms, hands, lower legs, or feet
- decreased urination
- fast, pounding, or irregular heartbeat or pulse
- pain in the lower abdomen, groin, upper back, or sides
- rapid weight gain
- tingling of the hands or feet
- unusual weight gain or loss
Incidence not known
- Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals
Other side effects of Utibron Neohaler
Some side effects of glycopyrrolate / indacaterol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- voice changes
For Healthcare Professionals
Applies to glycopyrrolate / indacaterol: inhalation capsule.
The most common adverse reaction was nasopharyngitis and hypertension. Cough was also common, but usually of mild intensity.[Ref]
Very common (10% or more): Upper and lower respiratory tract infection
Common (1% to 10%): Nasopharyngitis (4.1%), oropharyngeal pain (1.6%), pneumonia, rhinitis, sinusitis, cough, throat irritation
Uncommon (0.1% to 1%): Paradoxical bronchospasm, epistaxis
Very rare (less than 0.01%): Chest pain[Ref]
Uncommon (0.1% to 1%): Dry mouth[Ref]
Common (1% to 10%): Hyperglycemia
Common (1% to 10%): Back pain, musculoskeletal pain
Uncommon (0.1% to 1%): Muscle spasm, myalgia, pain in extremity[Ref]
Common (1% to 10%): Dizziness, headache
Uncommon (0.1% to 1%): Paraesthesia[Ref]
Common (1% to 10%): Pyrexia
Very rare (less than 0.01%): Atrial fibrillation, palpitations, tachycardia[Ref]
Frequently asked questions
More about Utibron Neohaler (glycopyrrolate / indacaterol)
Related treatment guides
1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
2. Canadian Pharmacists Association "e-CPS. http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink" (2006):
3. Cerner Multum, Inc. "Australian Product Information." O 0
4. "Product Information. Utibron Neohaler (glycopyrrolate-indacaterol)." Novartis Pharmaceuticals
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.